Salicylic Acid

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the removal of common and plantar warts. Common warts are characterized by their rough, 'cauliflower-like' surface appearance, while plantar warts are specifically located on the bottom of the foot and disrupt the normal footprint pattern.

Limitations of Use: There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The affected area should be washed thoroughly, and warts may be soaked in warm water for approximately 5 minutes to facilitate treatment. After soaking, the area must be dried completely.

A small amount of the wart remover should be applied using the provided applicator, ensuring that each wart is sufficiently covered. This application should be allowed to dry before proceeding. The procedure may be repeated once or twice daily, continuing until the wart is removed, with a maximum treatment duration of up to 12 weeks.

Contraindications

Use of this product is contraindicated in the following situations:

Patients with diabetes or poor blood circulation should not use this product unless under the advice and supervision of a healthcare professional, such as a doctor or podiatrist, due to the increased risk of complications.

Application is contraindicated on irritated, infected, or reddened skin, as this may exacerbate the condition.

The product should not be applied to genital warts or warts located on the face, as these areas may require specialized treatment.

It is also contraindicated for use on moles, birthmarks, and warts with hair growing from them, due to the potential for adverse effects.

Application to mucous membranes is prohibited, as this may lead to irritation or other complications.

Warnings and Precautions

For external use only, this product is flammable and should be kept away from fire or flame. It is essential to cap the bottle tightly and store it at room temperature, away from heat sources.

General precautions must be observed to ensure safe use. This product should not be used by individuals with diabetes or poor blood circulation unless under the advice and supervision of a qualified healthcare professional, such as a doctor or podiatrist. It is contraindicated for application on irritated, infected, or reddened skin, as well as on genital warts, facial warts, moles, birthmarks, and warts with hair growing from them. Additionally, this product should not be applied to mucous membranes.

In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is advised.

Users should discontinue use and consult a healthcare provider if discomfort persists.

Side Effects

Patients should be aware of several important considerations regarding the use of this product. It is contraindicated for individuals who are diabetic or have poor blood circulation, unless used under the advice and supervision of a healthcare professional, such as a doctor or podiatrist. Additionally, the product should not be applied to irritated, infected, or reddened skin, nor should it be used on genital warts, warts on the face, moles, birthmarks, or warts with hair growing from them. It is also not recommended for use on mucous membranes.

During the application of this product, patients should avoid contact with the eyes. In the event that the product comes into contact with the eyes, it is advised to flush the eyes with water for 15 minutes. Furthermore, patients should take care to avoid inhaling vapors associated with the product.

Patients are advised to discontinue use and consult a healthcare professional if discomfort persists. It is crucial to keep this product out of reach of children. In the case of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Salicylic Acid (wart remover liquid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the local Poison Control Center should be contacted without delay.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients.

Due to the lack of data, it is advisable to closely monitor elderly patients for any potential adverse effects and to consider individual patient factors when determining the appropriateness of therapy.

Pregnancy

Pregnant patients should be advised against the use of this product, particularly if they have diabetes or poor blood circulation, unless under the guidance and supervision of a healthcare professional. The safety of this product during pregnancy has not been established, and its use on irritated, infected, or reddened skin is contraindicated. Additionally, it should not be applied to genital warts, facial warts, moles, birthmarks, or warts with hair growing from them, nor should it be used on mucous membranes.

Healthcare providers should counsel pregnant patients to avoid contact with the eyes when using this product. In the event of accidental exposure to the eyes, it is recommended to flush with water for 15 minutes. If discomfort persists, patients should discontinue use and consult their healthcare provider. As with all medications, this product should be kept out of reach of children, and immediate medical assistance should be sought if ingested.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or its effects on lactation. Additionally, no data are provided concerning the excretion of this medication in breast milk or its potential effects on breastfed infants. Healthcare professionals should consider the lack of information when advising lactating mothers about the use of this medication.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the drug insert text regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the lack of data necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in these patients to ensure safety and efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved; therefore, a thorough assessment by a medical professional is recommended to determine the appropriate course of action.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. It is imperative that healthcare providers remain vigilant and prepared to address any complications that may arise from an overdosage scenario.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question. Further studies may be necessary to elucidate these aspects of nonclinical toxicology.

Postmarketing Experience

No postmarketing experience details are available in the provided text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. It is crucial to emphasize the importance of seeking immediate medical assistance or contacting a Poison Control Center if the medication is swallowed. This information is vital for ensuring patient safety and preventing potential harm.

Storage and Handling

The product is supplied in a tightly capped bottle. It is essential to store the bottle at room temperature, ensuring it is kept away from heat sources. The recommended storage temperature range is between 20°C to 30°C (68°F to 86°F). Additionally, it is crucial to keep the product away from fire or flame to ensure safety and integrity.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Salicylic Acid, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)